(Q52421385)

1 May 2018

title

An updated dose-response analysis in Hodgkin's disease (English)

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

16 October 2022

author name string

S. Vijayakumar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1620882

16 October 2022

L. C. Myrianthopoulos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1620882

16 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1620882

16 October 2022

publication date

1 May 1992

1 reference

1 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:016781409290347W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

https://api.elsevier.com/content/article/PII:016781409290347W?httpAccept=text/plain

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Radiotherapy and Oncology

16 October 2022

published in

1 reference

1 May 2018

volume

24

1 reference

1 May 2018

issue

1

1 reference

1 May 2018

page(s)

1-13

1 reference

1 May 2018

The Late Appearance of Chronic Pericardial Disease in Patients Treated by Radiotherapy for Hodgkin's Disease

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Long-term cardiovascular evaluation of patients with Hodgkin's disease treated by thoracic mantle radiation therapy

16 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Coronary heart disease mortality after irradiation for Hodgkin's disease

16 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Concomitant illness in patients treated for Hodgkin's disease

16 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart

16 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Detection of radiation cardiomyopathy by gated radionuclide angiography

16 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications

16 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Complications from large field intermediate dose infradiaphragmatic radiation: an analysis of the patterns of care outcome studies for Hodgkin's disease and seminoma

16 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Salient factors in the treatment of Hodgkin's disease and lymphosarcoma with roentgen rays

16 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Cure of Hodgkin's Disease.

16 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Management of stage I and II Hodgkin's disease.

16 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Keynote address: The scientific basis of the present and future practice of clinical radiotherapy

16 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Further follow-up of results of treatment in 90 laparotomy-negative stage I and II Hodgkin's disease patients: significance of mediastinal and non-mediastinal presentations

16 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Late cardiac effects of therapeutic mediastinal irradiation. Assessment by echocardiography and radionuclide angiography

16 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease

16 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Patterns of care outcome studies in Hodgkin's disease: results of the national practice and implications for management

16 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Patterns of care study: Hodgkin's disease relapse rates and adequacy of portals

16 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Patterns of care outcome studies. Results of the national practice in Hodgkin's disease

16 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

The contemporary management of Hodgkin disease

16 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

The management of stage II Hodgkin's disease with a large mediastinal mass: a prospective program emphasizing irradiation

16 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

LYMPHOMAS: RELATIONSHIP BETWEEN DOSAGE AND RECURRENCE

16 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Leukemia following Hodgkin's disease

16 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Cardiopulmonary Function in Long-Term Survivors of Childhood Hodgkin's Lymphoma: A Pilot Study

16 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin's disease

16 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Late effects of radiation therapy in the treatment of Hodgkin's disease

16 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Patterns of care study: Hodgkin's disease relapse rates and adequacy of portals

16 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Cardiac effects of mediastinal irradiation

16 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer

16 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Coronary heart disease after mediastinal irradiation for Hodgkin's disease

16 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Radiation-induced accelerated coronary arteriosclerosis

16 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease

16 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Echocardiographic abnormalities following cardiac radiation

16 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

The place of irradiation in the control of Hodgkin's disease

16 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

A study of Hodgkin's disease treated by irradiation

16 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Prophylactic treatment of adjacent areas in Hodgkin's disease

16 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease

16 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

The never-ending controversies in Hodgkin's disease

16 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Evidence for an orderly progression in the spread of Hodgkin's disease

16 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

A step toward ending the controversies in Hodgkin's disease

16 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Total dose, fraction size, and tumor volume in the local control of Hodgkin's disease

16 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

TIME-DOSE RELATIONSHIPS IN HODGKIN'S DISEASE

16 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Time-Dose-Volume Relationship in Hodgkin's Disease

16 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Long-term side effects in irradiated patients with Hodgkin's disease

16 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Tumor burden as the most important prognostic factor in early stage Hodgkin's disease.Relations to other prognostic factors and implications for choice of treatment

16 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Hodgkin's disease, stages I and II.Relationship of recurrence to size of disease, radiation dose, and number of sites involved

16 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

Radiation-related chronic heart disease

16 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0167-8140(92)90347-W

16 October 2022

Identifiers

1 reference

1 May 2018

1 reference

1 May 2018